Abstract
Recent reports describing a direct stimulation by GH of bone and cartilage growth led us to compare the in vitro mitogenic effects of highly purified human GH and PRL and two pituitary-derived growth factors in rabbit articular chondrocytes. These preparations were tested for their ability to promote [3H]thymidine incorporation into growth-arrested monolayer chondrocyte cultures and were also assayed in cell growth experiments. The factors tested included 22,000-dalton and 20,000-dalton human GH ovine PRL, glycosylated ovine PRL, bovine pituitary fibroblast growth factor (bpFGF), and a partially purified pituitary growth factor distinct from bpFGF. We found that no significant mitogenic effect was produced by either of the human GH or PRL preparations. Both of the pituitary-derived growth factors were potent mitogens, with bpFGF active at a final medium concentration of 10 pg/ml. These studies support the large body of evidence that GH has no significant direct in vitro effect on chondrocyte growth. The very potent effects of the pituitary-derived growth factors raise the possibility that their presence in GH preparations may be responsible for the in vitro mitogenic effects attributed to these preparations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.